Vynleads (VYND) Revenue (2020 - 2022)

Vynleads (VYND) posted quarterly Revenue of $49.0 for Q2 2022, down 75.86% year-over-year from $203.0 in Q2 2021, and down 75.86% quarter-over-quarter from $203.0 in Q2 2021.

Vynleads (VYND) Revenue (2020 - 2022) Analysis & Trends

Vynleads (VYND) has reported Revenue for 3 consecutive years, with $49.0 the latest figure, recorded in Q2 2022.

  • In Q2 2022, Revenue fell 75.86% year-over-year to $49.0; the TTM figure through Mar 2023 stood at $49.0 (changed N/A YoY), while the FY2022 annual figure was $49.0, down 89.88% from the prior year.
  • Revenue slipped to $49.0 in Q2 2022 per VYND's latest filing, from $203.0 in the prior quarter.
  • Across five years, Revenue topped out at $23388.0 in Q1 2020 and bottomed at $49.0 in Q2 2022.
  • Historically, Revenue has averaged $6970.7 across 3 years, with a median of $770.0 in 2020.
  • Annual changes were most pronounced in 2021 — Revenue slumped 98.8% — and 2022, when it slumped 75.86%.
  • Vynleads' Revenue stood at $770.0 in 2020, then sank by 73.64% to $203.0 in 2021, then plunged by 75.86% to $49.0 in 2022.
  • Business Quant data shows VYND's Revenue at $49.0 in Q2 2022, $203.0 in Q2 2021, and $281.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 882.95 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 3.87 Bn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 354.64 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 151.04 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 212.82 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 837.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 319.67 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 156.62 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 64.08 Mn
10 Vynleads 7.51 Mn 7.51 Mn -2,028.00 -

Historic Data

Download Data
DateValue
Jun 30, 2022 49.00
Jun 30, 2021 203.00
Mar 31, 2021 281.00
Dec 31, 2020 770.00
Sep 30, 2020 8,379.00
Jun 30, 2020 15,725.00
Mar 31, 2020 23,388.00